GPT Healthcare

38
Sell
  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE486R01017
  • NSEID: GPTHEALTH
  • BSEID: 544131
INR
143.70
2.3 (1.63%)
BSENSE

Dec 05

BSE+NSE Vol: 68.88 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
GPT Healthcare Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
Profit Before Tax
54.00
28.00
14.00
Adjustment
19.00
20.00
22.00
Changes In working Capital
5.00
-9.00
4.00
Cash Flow after changes in Working Capital
79.00
40.00
41.00
Cash Flow from Operating Activities
65.00
42.00
41.00
Cash Flow from Investing Activities
-5.00
-16.00
-54.00
Cash Flow from Financing Activities
-57.00
-22.00
11.00
Net Cash Inflow / Outflow
3.00
4.00
0.00
Opening Cash & Cash Equivalents
4.00
0.00
1.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
Closing Cash & Cash Equivalent
8.00
4.00
0.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of GPT Healthcare
Markets Mojo
Figures in Cr
standaloned Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
69.35
31.6
38.00
119.46%
Adjustment
18.74
27.9
-9.00
-32.83%
Changes In working Capital
-3.61
4.82
-7.00
-174.90%
Cash Flow after changes in Working Capital
84.48
64.33
20.00
31.32%
Cash Flow from Operating Activities
67.4
57.58
10.00
17.05%
Cash Flow from Investing Activities
-32.59
-50.94
18.00
36.02%
Cash Flow from Financing Activities
-34.84
-2.3
-32.00
-1414.78%
Net Cash Inflow / Outflow
-0.03
4.34
-4.00
-100.69%
Opening Cash & Cash Equivalents
1.69
4.85
-3.00
-65.15%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
1.66
9.19
-8.00
-81.94%
Cash Flow - Snapshot (Standalone) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -2.03% vs 3.68% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
67.40
68.80
-2.03%